Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Dana-Farber/Harvard Cancer Center Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for certified medical advice, visits or treatment by using a real doctor. We aren't doctors. Always confer with your physician on Dana-Farber/Harvard Cancer Center clinical studies. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Dana-Farber/Harvard Cancer Center Clinical research trials and Dana-Farber/Harvard Cancer Center health trials take place in hundreds of cities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectiveness of new does drugs. The aim of the studies / projects is to solve certain human health questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations like Dana-Farber/Harvard Cancer Center to discover remedies for all varieties of conditions. Dana-Farber/Harvard Cancer Center Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the masses. Many times the human subjects undergo professional assistance for without cost, and occasionally they are paid for their time. Occasionally there is a cost for a Dana-Farber/Harvard Cancer Center clinical trial. Human subjects often recieve the best healthcare possible for their condition. Hazards are a reality, however, and might include more or frequent dr. calls, medical risks (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > "D" Clinical Trials Sponsors > Dana-Farber/Harvard Cancer Center Clinical Trials

Dana-Farber/Harvard Cancer Center Clinical Trials



Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Chemotherapy With or Without Docetaxel Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Epirubicin and Thalidomide in Treating Patients With Liver Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Flavopiridol in Treating Patients With Metastatic or Unresectable Mantle Cell Lymphoma, Squamous Cell Carcinoma of the Head and Neck, Small Cell Lung Cancer, or Invasive Breast Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Gemcitabine and Flavopiridol in Treating Patients With Solid Tumors
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

KRN5500 in Treating Patients With Solid Tumors
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Valdecoxib in Treating Chronic Pain in Cancer Patients
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center



Dana-Farber/Harvard Cancer Center Clinical Trials

Modify your Search

Other "D" Clinical Trials Sponsors:

Daiichi Pharmaceuticals
Dana-Farber/harvard Cancer Center
Dekk-Tec
Dendreon
Department Of Education
Department Of Veterans Affairs
Department Of Veterans Affairs Cooperative Studies Program
Department Of Veterans Affairs Medical Research Service
Department Of Veterans Affairs Rehabilitation Research And Development Service
Dermatologische Klinik Mit Poliklinik-Universitaetsklinikum Erlangen
Direct Therapeutics
Duke Comprehensive Cancer Center
Duke University
Dupont Merck
Dupont Pharmaceuticals
Dynport Vaccine Company


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103